MoneyWorks4Me

Suven Life Sciences - Quaterly Results

08 Aug 2023 Evaluate
A fair growth of 7.29% in the revenue at Rs. 37.97 millions was reported in the June 2023 quarter as compared to Rs. 35.39 millions during year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -28.71 millions as compared to Net Loss of Rs. -23.13 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 further decreased to -11.55% as compared to -66.30% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 37.97 35.39 7.29 37.97 35.39 7.29 135.39 118.44 14.31
Other Income 56.40 4.36 1193.58 56.40 4.36 1193.58 84.49 16.01 427.73
PBIDT -11.55 -66.30 -82.58 -11.55 -66.30 -82.58 -192.95 -350.41 -44.94
Interest 0.51 1.02 -50.00 0.51 1.02 -50.00 2.89 5.30 -45.47
PBDT -12.06 -7.32 64.75 -12.06 -7.32 64.75 -135.84 -318.55 -57.36
Depreciation 16.65 15.81 5.31 16.65 15.81 5.31 65.43 43.93 48.94
PBT -28.71 -23.13 24.12 -28.71 -23.13 24.12 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -28.71 -23.13 24.12 -28.71 -23.13 24.12 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -30.42 -187.34 -83.76 -30.42 -187.34 -83.76 -142.51 -295.85 -51.83
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..